Medical Data Vision Co (TSE:3902) PE Ratio: 227.57 (As of Aug. 14, 2026) — 98% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3902 Medical Data Vision Co Ltd TSE:3902
56 GF Score
Price 円1,684.00
GF Value 円657.61
! 7 Warning Signs
View Full Analysis

What is Medical Data Vision Co PE Ratio?

Medical Data Vision Co TSE:3902 56 PE Ratio is 227.57 as of Aug. 14, 2026, which is 98% above its 10-year median of 115.12. GuruFocus rates TSE:3902 with a GF Score™ of 56/100 and a GF Value™ of 円657.61. The stock has 7 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-14), Medical Data Vision Co's share price is 円1684.00. Medical Data Vision Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円7.40. Therefore, Medical Data Vision Co's PE Ratio for today is 227.57.

Warning Sign:

Medical Data Vision Co Ltd stock PE Ratio (=227.57) is close to 5-year high of 228.51.

During the past 13 years, Medical Data Vision Co's highest PE Ratio was 876.44. The lowest was 14.63. And the median was 115.12.

Medical Data Vision Co's EPS (Diluted) for the six months ended in Dec. 2025 was 円7.67. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円7.40.

As of today (2026-08-14), Medical Data Vision Co's share price is 円1684.00. Medical Data Vision Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was 円13.33. Therefore, Medical Data Vision Co's PE Ratio without NRI ratio for today is 126.33.

During the past 13 years, Medical Data Vision Co's highest PE Ratio without NRI was 641.56. The lowest was 13.52. And the median was 106.87.

Medical Data Vision Co's EPS without NRI for the six months ended in Dec. 2025 was 円13.62. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was 円13.33.

During the past 3 years, the average EPS without NRI Growth Rate was -21.80% per year.

During the past 13 years, Medical Data Vision Co's highest 3-Year average EPS without NRI Growth Rate was 126.80% per year. The lowest was -21.80% per year. And the median was 17.90% per year.

Medical Data Vision Co's EPS (Basic) for the six months ended in Dec. 2025 was 円7.67. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was 円7.40.

Back to Basics: PE Ratio


Medical Data Vision Co  (TSE:3902) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Medical Data Vision Co PE Ratio Related Terms


Medical Data Vision Co PE Ratio Historical Data

* Premium members only.

The historical data trend for Medical Data Vision Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Data Vision Co PE Ratio Chart

Medical Data Vision Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.92 39.46 25.56 At Loss 228.11

Medical Data Vision Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.56 51.20 At Loss N/A 228.11

TSE:3902 vs VEEV, TEM, BTSG: PE Ratio Comparison

For the Health Information Services subindustry, Medical Data Vision Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Data Vision Co PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medical Data Vision Co's PE Ratio falls into.


TSE:3902
56GF Score
Medical Data Vision Co Ltd TSE:3902
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Data Vision Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Medical Data Vision Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=1684.00/7.400
=227.57

Medical Data Vision Co's Share Price of today is 円1684.00.
For company reported semi-annually, Medical Data Vision Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円7.40.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 227.57 mean?
Medical Data Vision Co (TSE:3902) has a PE Ratio of 227.57 as of Aug. 14, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Medical Data Vision Co and its competitors. This is 98% above median its historical median of 115.12. Over the past decade, Medical Data Vision Co's PE Ratio has ranged from 14.63 to 876.44.
Is Medical Data Vision Co's PE Ratio too high?
Medical Data Vision Co's current PE Ratio of 227.57 is 98% above median its 10-year median of 115.12. Over the past 10 years, this metric has ranged from a low of 14.63 to a high of 876.44. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's PE Ratio compare to VEEV and TEM?
Medical Data Vision Co's PE Ratio of 227.57 can be compared against companies in the Healthcare Providers & Services industry. Historically, Medical Data Vision Co's own PE Ratio has ranged from 14.63 to 876.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Healthcare Providers & Services company?
A good PE Ratio depends on the Healthcare Providers & Services industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Medical Data Vision Co and its competitors. Medical Data Vision Co's current PE Ratio is 227.57, which is 98% above median its own 10-year median of 115.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current PE Ratio of 227.57. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current PE Ratio is 227.57, which is 98% above median its 10-year median of 115.12. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current PE Ratio is 227.57 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued. The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.

Key valuation signals for TSE:3902:

  • PE Ratio: 227.57 (98% above median its 10-year median of 115.12)
  • GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Data Vision Co Business Description

Address 7, Kandamitoshirocho, Chiyoda-ku, Tokyo, JPN, 101-0053
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score

Get the complete analysis for TSE:3902

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,684.00
Price
円657.61
GF Value